CTRI/2024/04/066324尚未招募2 期
Tumor microenvironment modulation therapy in breast-cancer-subtypes and single-cell genomics-based patient stratification for improved low-dose immunotherapy: Preclinical and Clinical study - NI
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Women aged 18 and above with Breast Cancer of the subtypes Luminal B Her2-ve and TNBC
- •2.Women with advanced stages of Luminal B Her2-ve and TNBC that are inoperable but non-metastatic
- •3.Women with Luminal B Her-ve and TNBC that are eligible for NACT
排除标准
- •Exclusion Criteria:
- •1.Women with early-stage Luminal B Her-ve and TNBC tumors that are taken up for primary surgery will be excluded
- •2.Women with Luminal B tumors that are HER2 positive will be excluded
- •3.Women with Luminal A tumors will be excluded
- •4.Women with the above subtypes of BC having HIV, HCV, and HBV infections will be excluded from the study
- •5.Women undergoing treatment for BC or any other types of cancer will be excluded
- •6.Women with any other cancers will be excluded
研究者
相似试验
进行中（未招募）
1 期
Prime RT - using chemotherapy and radiotherapy to charge the immune system making immunotherapies more effective in boosting anti-cancer immune responses in rectal cancerRectal Cancer.MedDRA version: 20.0Level: PTClassification code 10038038Term: Rectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2019-001471-36-GBHS Greater Glasgow and Clyde54
进行中（未招募）
不适用
Comparing two different regimens of radiotherapy, combined with durvalumab immunotherapy and chemotherapy, in improving the response of rectal cancer to treatmentocally advanced rectal cancerMalignant neoplasm of rectumCancerISRCTN18138369HS Greater Glasgow and Clyde46
已完成
2 期
Modulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal CancerColorectal Cancer MetastaticNCT03647839Australasian Gastro-Intestinal Trials Group90
招募中
不适用
Exploratory biomarker study on tumor microenvironment using pre-treatment and refractory archival samples of hepatocellular carcinomaJPRN-UMIN000047701Chiba University Hospital60
招募中
不适用
Research for cancer microenvironment by measuring exosome into ovarian venous bloodovarian cancerJPRN-UMIN000015294Osaka medical university100